| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 01/12/2012 | WO2012003544A1 Protein kinase inhibitors and methods of treatment |
| 01/12/2012 | WO2011123678A3 Substituted benzo-pyrido-triazolo-diazepine compounds |
| 01/12/2012 | WO2011112731A3 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 01/12/2012 | WO2011103202A3 Androgen receptor modulators and uses thereof |
| 01/12/2012 | WO2010135524A8 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases |
| 01/12/2012 | US20120010409 Improved chemical synthesis of diazaindoles by chichibabin cyclization |
| 01/12/2012 | US20120010405 Optically active 3-amino-2,5-dioxopyrrolidine-3-carboxylate, process for production of the compound, and use of the compound |
| 01/12/2012 | US20120010334 Ionic liquids for solubilizing polymers |
| 01/12/2012 | US20120010261 Choline and tromethamine salt of licofelone |
| 01/12/2012 | US20120010235 N-substituted pyrrolidines |
| 01/12/2012 | US20120010228 D2 antagonists, methods of synthesis and methods of use |
| 01/12/2012 | US20120010224 6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines |
| 01/12/2012 | US20120010222 Gyrase Inhibitors and Uses Thereof |
| 01/12/2012 | US20120010209 IMIDAZO[1,2-A]PYRIDINES AND IMIDAZO[1,2-b]PYRIDAZINES AS MARK INHIBITORS |
| 01/12/2012 | US20120010203 Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments |
| 01/12/2012 | US20120010200 Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same |
| 01/12/2012 | US20120010199 Novel pyrrolinone derivative and pharmaceutical composition comprising the same |
| 01/12/2012 | US20120010197 Protein kinase inhibitors |
| 01/12/2012 | US20120010191 Pyridone and aza-pyridone compounds and methods of use |
| 01/12/2012 | US20120010186 Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/12/2012 | US20120009152 Nitric oxide donors for treatment of disease and injury |
| 01/12/2012 | CA2804648A1 Protein kinase inhibitors and methods of treatment |
| 01/12/2012 | CA2804470A1 Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases |
| 01/12/2012 | CA2804137A1 Fused heterocyclic derivatives as s1p modulators |
| 01/12/2012 | CA2803876A1 Metallation enhancements in tumor-imaging and pdt therapy |
| 01/12/2012 | CA2803448A1 Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators |
| 01/11/2012 | EP2404923A1 7-azabicyclo[2.2.1]heptane derivatives useful for promoting smoking cessation |
| 01/11/2012 | EP2404922A1 Quinoxaline compounds |
| 01/11/2012 | EP2404921A1 Salts of tetrahydroimidazo ý1,5-a¨pyrazine derivatives, preparation methods and pharmaceutical use thereof |
| 01/11/2012 | EP2403855A1 Carbazole linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof |
| 01/11/2012 | EP2403854A1 Sulfonylated tetrahydroazolopyrazines and their use as medicinal products |
| 01/11/2012 | EP2403853A1 Pyrrolopyrimidines used as kinase inhibitors |
| 01/11/2012 | EP2403833A1 8-substituted quinolines and related analogs as sirtuin modulators |
| 01/11/2012 | EP2152712B1 Amino-heterocyclic compounds |
| 01/11/2012 | EP1991549B1 Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators |
| 01/11/2012 | EP1913000B1 Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis |
| 01/11/2012 | EP1891072B1 Substituted 7,8-Dihydro-1H-pyrimido[4,5-b]diazepin-4-amines as kinase inhibitors |
| 01/11/2012 | EP1888066B1 Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 01/11/2012 | EP1881983B1 Pyrrolopyridines useful as inhibitors of protein kinase |
| 01/11/2012 | EP1846406B9 Maleimide derivatives, pharmaceutical compositions and methods for treatment of cancer |
| 01/11/2012 | EP1399514B1 Fluorescent diketopyrrolopyrroles |
| 01/11/2012 | CN1989140B Compounds containing a n-heteroaryl moiety linked to fused ring moieties for the inhibition of nad(p)h oxidases and platelet activation |
| 01/11/2012 | CN102318101A Material for phosphorescent light-emitting element and organic electroluminescent element using same |
| 01/11/2012 | CN102317291A Fused pyrimidines |
| 01/11/2012 | CN102317290A STAT3 inhibitors and therapeutic methods using the same |
| 01/11/2012 | CN102317286A 2-(piperidin-1-yl)-4-heterocyclyl-thiazole-5-carboxylic acid derivatives against bacterial infections |
| 01/11/2012 | CN102317270A Isoxazole-isoxazole and isoxazole-isothiazole derivatives |
| 01/11/2012 | CN102311504A Polysaccharide derivative and preparation method thereof and separating agent |
| 01/11/2012 | CN102311454A Compound lipid containing porphyrin ring functional groups, intermediate, preparation method and application thereof |
| 01/11/2012 | CN102311447A Heterocyclo pyrimidone dipeptidyl peptidase-IV (DPP-IV) inhibitor |
| 01/11/2012 | CN102311441A Production method of sodium copper chlorophyllin |
| 01/11/2012 | CN102311440A 1-methoxycarbonyl-3-benzyl-8-tertiarybutoxy carbonyl-3,8-diazabicyclo [3.2.1] octane and preparation method |
| 01/11/2012 | CN102311439A 1-substituted-3,8-diazabicyclo[3.2.1] octane derivative and preparation method thereof |
| 01/11/2012 | CN102311438A Quinazoline compound |
| 01/11/2012 | CN102311437A Preparation method of platelet-aggregation-resisting medicament Ticagrelor |
| 01/11/2012 | CN102311403A 4,5-diaminocyclopentyl-2-enol derivative |
| 01/11/2012 | CN101717401B Preparing method of phthalocyaninatoaluminium chloride |
| 01/11/2012 | CN101528226B Fluorinated ligands for targeting peripheral benzodiazepine receptors |
| 01/11/2012 | CN101327451B Uses of planar polymerized phthalocyanine or porphyrin transition metal complexes |
| 01/11/2012 | CN101146811B Hiv integrase inhibitors |
| 01/10/2012 | USRE43098 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof |
| 01/10/2012 | US8093403 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 01/10/2012 | US8093383 P70 S6 kinase inhibitors |
| 01/10/2012 | US8093380 Compounds with the bicyclo[4.2.1]nonane system for the treatment of Flaviviridae infections |
| 01/10/2012 | US8093379 Macrocyclic serine protease inhibitors |
| 01/10/2012 | US8093257 [6,5]-bicyclic GPR119 G protein-coupled receptor agonists |
| 01/10/2012 | US8093256 Use of 8-substituted-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 01/10/2012 | US8093255 Imidazo[1,2-A]pyrimidines as orexin receptor antagonists |
| 01/10/2012 | US8093254 Aspartyl protease inhibitors |
| 01/10/2012 | US8093249 Pyrazolo[1,5-A]pyrimidine-carbonyl-piperazine derivatives |
| 01/10/2012 | US8093240 Triazole derivatives |
| 01/10/2012 | US8093229 Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as HSP90-inhibitors |
| 01/10/2012 | CA2623982C Pyrazolo[1,5-a]pyrimidine compounds as cannabinoid receptor antagonists |
| 01/10/2012 | CA2557781C 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds |
| 01/10/2012 | CA2533332C Therapeutic compounds |
| 01/05/2012 | WO2012003498A1 2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds |
| 01/05/2012 | WO2012003271A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 01/05/2012 | WO2012003262A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 01/05/2012 | WO2012002568A1 Azaindole derivative |
| 01/05/2012 | WO2012002527A1 HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR |
| 01/05/2012 | WO2012001708A1 Process for preparing of dioxazine pigments |
| 01/05/2012 | WO2012001308A1 Method for synthesizing ergoline alkaloids from indolic bicyclic compounds by double cyclization, resulting materials, and intermediate materials |
| 01/05/2012 | WO2012001194A1 Cation derivatives of 2,7,12,17-aryl porphycenes, preparation method thereof and use of same as photosensitisers in antimicrobial photodynamic therapy |
| 01/05/2012 | WO2012001107A1 Piperidine derivatives and their use for the treatment of metabolic disorders |
| 01/05/2012 | WO2012000304A1 Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof |
| 01/05/2012 | WO2012000212A1 Compound for inhibiting type 5 phosphodiesterase and preparation method thereof |
| 01/05/2012 | WO2012000182A1 Quinazoline compounds |
| 01/05/2012 | WO2011116371A3 Polyplex gene delivery vectors |
| 01/05/2012 | WO2011093672A3 Bicyclic heteroaryl derivatives having inhibitory activity for protein kinase |
| 01/05/2012 | WO2011090317A3 Imidazopyrazinone derivatives with apoptosis inducing activity on cells |
| 01/05/2012 | US20120004384 Substituted benzazoloporphyrazines for polymerization and surface attachment and articles formed therefrom |
| 01/05/2012 | US20120004377 Clathrate, curing agent, cure accelerator, epoxy resin composition, and epoxy resin composition for encapsulation of semiconductor |
| 01/05/2012 | US20120004253 Novel Fused Pyrrolocarbazoles |
| 01/05/2012 | US20120004237 Salt of cd 80 antagonist |
| 01/05/2012 | US20120004234 Phthalazine-containing antidiabetic compounds |
| 01/05/2012 | US20120004233 Tricyclic compounds as antagonists of prostaglandin d2 receptors |
| 01/05/2012 | US20120004214 N-oxides of 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives useful as nicotinic acetylcholine receptor ligands |
| 01/05/2012 | US20120004203 Triazolo and tetrazolo pyrimidine derivatives as hne inhibitors for treating copd |
| 01/05/2012 | US20120003215 Pyrazolo[1,5-a]pyrimidines for antiviral treatment |
| 01/05/2012 | US20120001165 Material for phosphorescent light-emitting element and organic electroluminescent element using same |